Optic nerve head circulation after topical calcium channel blocker

Journal of Glaucoma

Volumn 5, Issue 3, 1996, Pages 200-206

  Netland, Peter A ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Calcium channel blocker; Glaucoma; Laser Doppler; Ocular blood flow; Verapamil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; PLACEBO; VERAPAMIL;

ADULT; ARTICLE; BLOOD FLOW; CAPILLARY BLOOD; CIRCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; MALE; NORMAL HUMAN; OPTIC NERVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

EID: 0029949529     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-199606000-00010     Document Type: Article

References (5)

1. Netland PA, Erickson KA. Calcium channel blockers in glaucoma management. Ophthalmol Clin North Am 1995;8: 327-34.
2. Monica HL, Hesse RJ, Messerli FH. The effect of a calcium-channel blocking agent on intraocular pressure [Letter]. Am J Ophthalmol 1983;96:814.
3. Schnell D. Response of intraocular pressure in normal subjects and glaucoma patients to single and repeated doses of the coronary drug adalat. In: Lochner W, Engel HJ, Lichtlen PR, editors. Second International Adalat Symposium. Berlin: Springer Verlag, 1975:290-302.
4. Abelson MB, Gilbert CM, Smith LM. Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil. Am J Ophthalmol 1988;105:155-9.
5. Goyal JK, Khilnani G, Sharma DP, Singh J. The hypotensive effect of verapamil eye drops on ocular hypertension. Indian J Ophthalmol 1989;37:176-8.